The French Financial Markets Authority (AMF) issued a warning to the public about a fraudulent Forex investment offer promoted by the trading platform www.livaxxen.com (LIVAXXEN). The AMF noted that it added the site to its Forex blacklist on 7 October 2024, but continues to receive a high volume of investor reports and complaints. LIVAXXEN presents itself as a multi-market trading platform covering currencies, indices and commodities, and advertises leverage of 400. The AMF stated that the platform has no authorisation to provide investment services in Europe and reminded investors that only firms authorised as investment services providers in the European Union may offer brokerage services such as Forex or index trading. It also highlighted the risks of leverage, including the possibility of losses exceeding the initial investment, and referred to European leverage caps designed to limit investor losses. The AMF reported that complainants describe aggressive solicitation by purported sales staff and persistent follow-ups by supposed traders encouraging additional investments, and that investors seeking to withdraw alleged gains are asked to pay fees of several thousand euros. Average losses reported to the AMF are around EUR 25,000, and the regulator urged savers not to respond to the platform’s solicitations or relay its offer, while reiterating basic checks such as verifying authorisation status and consulting the AMF’s blacklists.

Original source View in tracker